SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (2170)11/30/2000 1:49:53 PM
From: Biomaven  Read Replies (2) | Respond to of 52153
 
george,

I agree that mandatory reporting post-approval (say for a limited time like a year) would be a very good idea. I'm not sure it would lead the FDA to loosen up on approvals however - every time they have to withdraw an approved drug it makes them look bad.

Here's a sample of what they would get:

citizen.org

Peter